| Dr Melissa Lee-agawa, MD | |
|
735 Fitzwatertown Rd, Suite 4, Willow Grove, PA 19090-1338 | |
| (215) 914-4400 | |
| (215) 657-4887 |
| Full Name | Dr Melissa Lee-agawa |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 13 Years |
| Location | 735 Fitzwatertown Rd, Willow Grove, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831506492 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | MD459757 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Holy Redeemer Hospital And Medical Center | Meadowbrook, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hr Physician Services | 0042109902 | 143 |
News Archive
Candelis announced today that it has reached a definitive agreement with Microsoft whereby Candelis' ASTRA cloud-hosted suite of services will provide for the secure transferring of patient digital medical images and studies to patients' Microsoft HealthVault accounts upon their request.
Women with intellectual and developmental disabilities have nearly double the rate of having another baby within a year of delivering compared to women without such disabilities, according to a new study published in CMAJ.
Regulus Therapeutics Inc. announced today that it has obtained exclusive rights from the University of Wuerzburg to intellectual property covering methods for modulating microRNA-21. Regulus scientists and collaborators have shown that microRNA-21, (miR-21), is dysregulated in mouse models of cardiac disease and fibrosis, and that antagonizing miR-21 with therapeutic oligonucleotides targeting miR-21 inhibits fibrosis and attenuates cardiac function in such models. Regulus is currently developing a microRNA therapeutic targeting miR-21 as an anti-fibrotic therapy.
Health IT connectivity leader VisionShare® Inc. announces it has achieved full accreditation with the Healthcare Network Accreditation Program (HNAP) from the Electronic Healthcare Network Accreditation Commission (EHNAC). EHNAC's HNAP accreditation recognizes excellence in health data processing and transactions and indicates compliance with industry-established standards and HIPAA regulations.
Researchers have discovered that a family of lipids (fats) contribute to the development of a serious aortic disease, by driving clotting in the blood vessel wall.
› Verified 9 days ago
| Entity Name | Hr Physician Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881696698 PECOS PAC ID: 0042109902 Enrollment ID: O20040311000028 |
News Archive
Candelis announced today that it has reached a definitive agreement with Microsoft whereby Candelis' ASTRA cloud-hosted suite of services will provide for the secure transferring of patient digital medical images and studies to patients' Microsoft HealthVault accounts upon their request.
Women with intellectual and developmental disabilities have nearly double the rate of having another baby within a year of delivering compared to women without such disabilities, according to a new study published in CMAJ.
Regulus Therapeutics Inc. announced today that it has obtained exclusive rights from the University of Wuerzburg to intellectual property covering methods for modulating microRNA-21. Regulus scientists and collaborators have shown that microRNA-21, (miR-21), is dysregulated in mouse models of cardiac disease and fibrosis, and that antagonizing miR-21 with therapeutic oligonucleotides targeting miR-21 inhibits fibrosis and attenuates cardiac function in such models. Regulus is currently developing a microRNA therapeutic targeting miR-21 as an anti-fibrotic therapy.
Health IT connectivity leader VisionShare® Inc. announces it has achieved full accreditation with the Healthcare Network Accreditation Program (HNAP) from the Electronic Healthcare Network Accreditation Commission (EHNAC). EHNAC's HNAP accreditation recognizes excellence in health data processing and transactions and indicates compliance with industry-established standards and HIPAA regulations.
Researchers have discovered that a family of lipids (fats) contribute to the development of a serious aortic disease, by driving clotting in the blood vessel wall.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Melissa Lee-agawa, MD 12265 Townsend Rd, Philadelphia, PA 19154-1201 Ph: (215) 856-1010 | Dr Melissa Lee-agawa, MD 735 Fitzwatertown Rd, Suite 4, Willow Grove, PA 19090-1338 Ph: (215) 914-4400 |
News Archive
Candelis announced today that it has reached a definitive agreement with Microsoft whereby Candelis' ASTRA cloud-hosted suite of services will provide for the secure transferring of patient digital medical images and studies to patients' Microsoft HealthVault accounts upon their request.
Women with intellectual and developmental disabilities have nearly double the rate of having another baby within a year of delivering compared to women without such disabilities, according to a new study published in CMAJ.
Regulus Therapeutics Inc. announced today that it has obtained exclusive rights from the University of Wuerzburg to intellectual property covering methods for modulating microRNA-21. Regulus scientists and collaborators have shown that microRNA-21, (miR-21), is dysregulated in mouse models of cardiac disease and fibrosis, and that antagonizing miR-21 with therapeutic oligonucleotides targeting miR-21 inhibits fibrosis and attenuates cardiac function in such models. Regulus is currently developing a microRNA therapeutic targeting miR-21 as an anti-fibrotic therapy.
Health IT connectivity leader VisionShare® Inc. announces it has achieved full accreditation with the Healthcare Network Accreditation Program (HNAP) from the Electronic Healthcare Network Accreditation Commission (EHNAC). EHNAC's HNAP accreditation recognizes excellence in health data processing and transactions and indicates compliance with industry-established standards and HIPAA regulations.
Researchers have discovered that a family of lipids (fats) contribute to the development of a serious aortic disease, by driving clotting in the blood vessel wall.
› Verified 9 days ago
Sherry L Blumenthal, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2701 Blair Mill Rd, Suite C, Willow Grove, PA 19090 Phone: 215-443-0660 Fax: 215-443-8422 | |
Frank Theodore Sandsorum Jr., MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2300 Computer Rd, Ste E25, Willow Grove, PA 19090 Phone: 215-659-8080 Fax: 215-659-0977 | |
Vahideh T Ameri, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 735 Fitzwatertown Rd, Suite 4, Willow Grove, PA 19090 Phone: 215-914-4400 Fax: 215-657-4887 | |
Patricia Ann Sullivan, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2701 Blair Mill Rd Ste C, Willow Grove, PA 19090 Phone: 215-443-0660 Fax: 215-443-8422 | |
Joseph James Murphy Iii, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2300 Computer Rd Ste E25, Willow Grove, PA 19090 Phone: 215-366-1160 Fax: 215-672-6853 | |
Jessica M. Klemens, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2701 Blair Mill Rd, Suite C, Willow Grove, PA 19090 Phone: 215-443-0660 Fax: 215-443-8422 | |
Dr. Elizabeth Burton, Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3941 Commerce Ave, Willow Grove, PA 19090 Phone: 215-481-4000 |